期刊文献+

Nanoparticle drug delivery system for the treatment of brain tumors:Breaching the blood–brain barrier

原文传递
导出
摘要 To the Editor:Malignant brain tumors represent a substantial morbidity and mortality burden globally,with 308,102 new cases and 251,329 cancer-related deaths in 20201.Brain tumors encompass primary tumors originating in the brain and brain metastases(BM)that have been spread from cancer lesions of other organs.Besides,BM are the most prevalent intracranial malignant tumor affecting approximately 20%-40%of cancer patients2.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第6期2786-2789,共4页 药学学报(英文版)
基金 supported by the grant National Natural Science Foundation of China(82272951,82272953) Beijing Municipal Health Commission(Beijing Demonstration Research Ward BCRW20200303) Chinese Academy of Medical Sciences(2022-I2M-C&T-B-070).
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部